What is the appropriate management for a patient with severely elevated blood pressure (hypertension)?

Management of Blood Pressure 202/107 mmHg

Immediate Assessment Priority

This patient requires urgent evaluation to determine if acute target organ damage is present—if present, this is a hypertensive emergency requiring ICU admission and IV therapy; if absent, this is hypertensive urgency manageable with oral medications and outpatient follow-up. 1

The blood pressure reading of 202/107 mmHg exceeds the threshold of 180/120 mmHg that defines severe hypertension, but the presence or absence of acute target organ damage—not the absolute BP number—determines the management pathway. 1, 2

---

Step 1: Assess for Acute Target Organ Damage

Immediately evaluate for signs of hypertensive emergency by assessing the following systems:

Neurologic Assessment

• Altered mental status, somnolence, or lethargy (hypertensive encephalopathy) 1
• Severe headache with vomiting 1
• Visual disturbances or seizures 1
• Focal neurologic deficits suggesting stroke 1

Cardiac Assessment

• Chest pain suggesting acute myocardial ischemia or infarction 1
• Dyspnea or signs of acute pulmonary edema 1
• Signs of acute heart failure 1

Vascular Assessment

• Symptoms suggesting aortic dissection (tearing chest/back pain) 1

Renal Assessment

• Acute deterioration in renal function 1
• Oliguria or signs of acute kidney injury 1

Ophthalmologic Assessment

• Fundoscopy for bilateral retinal hemorrhages, cotton wool spots, or papilledema (malignant hypertension) 1

---

Step 2: Management Based on Presence of Target Organ Damage

IF TARGET ORGAN DAMAGE IS PRESENT (Hypertensive Emergency)

Immediate ICU admission is required (Class I recommendation, Level B-NR). 1

Initial IV Medication Selection

Nicardipine is the preferred first-line agent for most hypertensive emergencies due to its predictable titration, rapid onset, and maintenance of cerebral blood flow. 1, 3

• Dosing: Start at 5 mg/hr IV infusion, titrate by 2.5 mg/hr every 15 minutes up to maximum 15 mg/hr until desired BP reduction achieved 1, 3
• Preparation: Each 25 mg vial must be diluted with 240 mL of compatible IV fluid (D5W, NS, or D5NS) resulting in 0.1 mg/mL concentration 3
• Administration: Via central line or large peripheral vein; change infusion site every 12 hours if peripheral 3

Alternative: Labetalol (preferred for encephalopathy, eclampsia, aortic dissection, or renal involvement) 1

• Dosing: 10-20 mg IV bolus over 1-2 minutes, repeat or double every 10 minutes (max cumulative 300 mg), OR 2-8 mg/min continuous infusion 1
• Contraindications: Reactive airway disease, COPD, heart block, bradycardia, decompensated heart failure 1

Blood Pressure Targets

Standard approach for most emergencies: 1

1. First hour: Reduce mean arterial pressure by 20-25%
2. Next 2-6 hours: If stable, reduce to 160/100 mmHg
3. Next 24-48 hours: Cautiously normalize BP

Critical exception—Aortic dissection: Target SBP ≤120 mmHg within 20 minutes using esmolol plus nitroprusside/nitroglycerin 1

Monitoring Requirements

• Continuous arterial line BP monitoring in ICU 1
• Serial assessment of target organ function 1
• Avoid excessive acute drops >70 mmHg systolic—this can precipitate cerebral, renal, or coronary ischemia 1, 2

---

IF NO TARGET ORGAN DAMAGE (Hypertensive Urgency)

This patient can be managed with oral medications and outpatient follow-up—hospital admission and IV medications are NOT necessary. 1, 2

Oral Medication Approach

Initiate or adjust oral antihypertensive therapy with combination therapy as first-line: 2, 4

Preferred initial regimen:

• Calcium channel blocker (amlodipine 5-10 mg daily) PLUS ACE inhibitor/ARB (lisinopril 10-40 mg daily or losartan 50-100 mg daily) 2, 4
• Alternative: CCB plus thiazide diuretic (chlorthalidone 12.5-25 mg daily) 2, 4

For Black patients specifically:

• CCB plus thiazide diuretic OR CCB plus ARB 2

Blood Pressure Targets

• Target SBP: 120-129 mmHg if tolerated, otherwise <130/80 mmHg for most adults 2, 4
• Reduce BP gradually over several days to weeks—NOT acutely 2

Follow-up

• Arrange outpatient follow-up within 2-4 weeks 2
• Monitor for orthostatic hypotension when intensifying therapy 4

---

Critical Pitfalls to Avoid

• Do NOT use immediate-release nifedipine—causes unpredictable precipitous BP drops and reflex tachycardia 1, 2, 5
• Do NOT rapidly lower BP in hypertensive urgency—this may cause harm through hypotension-related complications including acute kidney injury and stroke 1, 6
• Do NOT admit patients with asymptomatic hypertension without acute target organ damage—up to one-third normalize before follow-up 1
• Do NOT use IV medications for hypertensive urgency—oral therapy is appropriate 1, 2
• Do NOT lower BP to "normal" acutely in hypertensive emergency—patients with chronic hypertension have altered autoregulation and acute normalization can cause cerebral, renal, or coronary ischemia 1, 2

---

Post-Stabilization Considerations

• Screen for secondary hypertension causes (found in 20-40% of malignant hypertension cases): renal artery stenosis, pheochromocytoma, primary aldosteronism 1
• Address medication non-adherence—the most common trigger for hypertensive emergencies 1
• Evaluate for contributing factors: sympathomimetics, cocaine, NSAIDs, steroids, immunosuppressants 1